Schizophrenia may increase the abundance of 9 gut microbiota species and reduce the abundance of 2 taxa. A new study evaluating the relationship between the gut microbiome and schizophrenia risk ...

Zai Lab has reported positive outcomes from its Phase III clinical trial of KarXT (xanomeline and trospium chloride) in China ...

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with ...

Methods: Six double-blind, randomized, placebo-controlled, short-term clinical trials for acute schizophrenia ... Scale (PANSS) total score and baseline Clinical Global Impressions–Severity (CGI ...

Shares in Neurocrine Biosciences took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia ... and Negative Syndrome Scale (PANSS) total score after six ...

Zai Lab (ZLAB) announced positive topline results from the company’s Phase 3 multi-center trial evaluating the safety and efficacy of ...

Efficacy measurements included the Positive and Negative Syndrome Scale (PANSS) total score; and positive, negative, and general psychopathology scores; and the Clinical Global Impression of ...

A 31-year-old antipsychotic-naive woman with newly diagnosed schizophrenia developed tardive dyskinesia ... were "much ...

However, as robotics technologies scale, this is both a core area of opportunity and vulnerability for CGI, depending on management's foresight and execution. In addition to the risks in advanced ...

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Relative to placebo, lumateperone significantly improved MADRS, CGI-S, and QIDS-SR-16 scores by day 43 among patients with MDD.

Hi. I'm Michele Hammer and I have schizophrenia. Schizophrenia is a mental illness that changes the way you think, feel, and act. It's broken down into three separate categories, positive ...